XIANG D DONG
Allopathic & Osteopathic Physicians|Surgery|Surgical Oncology VALHALLA, NY NPI 1912970435
Browse related groups: Allopathic & Osteopathic Physicians|Surgery|Surgical Oncology NY BOSTON SCIENTIFIC CORPORATION All categories
General Payments — all program years on this page
$3,155.24
- Category: General Payments
- Program years: PY2018–2024
- Record count: 88
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $780.26 across 30 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $780.26 | 30 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $140.89 | 1 |
| Rigel Pharmaceuticals, Inc. | $103.68 | 5 |
| Lilly USA, LLC | $71.86 | 3 |
| Acerta Pharma LLC | $64.93 | 3 |
| Merck Sharp & Dohme Corporation | $51.25 | 2 |
| ARRAY BIOPHARMA INC | $45.52 | 2 |
| Incyte Corporation | $31.37 | 2 |
| Kerecis Limited | $29.51 | 1 |
| PharmaEssentia USA Corporation | $28.39 | 1 |
| Medtronic, Inc. | $27.20 | 1 |
| DAVOL INC. | $26.55 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.13 | 1 |
| EISAI INC. | $24.46 | 1 |
| Integra LifeSciences Corporation | $24.21 | 1 |
| Exelixis Inc. | $21.83 | 1 |
| Olympus America Inc. | $20.09 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $15.05 | 1 |
| Coherus Biosciences Inc. | $14.11 | 1 |
| Stemline Therapeutics Inc. | $13.23 | 1 |
By program year
Records — PY2024 (30)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.